Healthcare Giants and Schools Unite in Legal Battle Over Insulin Pricing
CVS Health, UnitedHealth Group, and Cigna have filed a lawsuit against the Federal Trade Commission (FTC), challenging the agency's case against pharmacy benefit managers (PBMs) over high insulin prices as unconstitutional. The companies argue that the FTC's administrative process violates their Fifth Amendment rights and should be handled in federal court. The FTC accuses the PBMs of inflating insulin costs through a rebate system. This legal battle follows the companies' request for FTC Chair Lina Khan and other commissioners to recuse themselves due to alleged bias.